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Abstract
Partial-thickness cartilage injuries do not heal effectively, 
potentially leading to degeneration as occurs in post-
traumatic osteoarthritis (PTOA). The role of chondrocytes 
could be crucial in determining the nature of the repair; 
however, their response to this injury is poorly understood. 
We have utilised an in vitro bovine osteochondral partial-
thickness scalpel injury model and determined chondrocyte 
properties at and distant from the injury in the presence/
absence of (a) serum-free DMEM (340 mOsm), (b) 
synovial fluid DMEM (SF-DMEM), (c) foetal calf serum 
DMEM (FCS-DMEM), (d) hyperosmolar serum-free 
DMEM (600 mOsm), or (e) hyperosmolar FCS-DMEM 
for up to two weeks. Chondrocytes were fluorescently-
labelled with 5-chloromethylfluorescein-diacetate 
(CMFDA)/propidium iodide (PI) for live/dead cells and 
imaged using confocal microscopy. Quantitative data were 
obtained on chondrocyte properties (cell volume, clusters, 
morphology) at and distant from the injury. In serum-free 
DMEM, chondrocyte morphology at the injury remained 
unaffected throughout culture. However, with SF-DMEM 
or FCS-DMEM the chondrocytes displayed an increase in 
volume (p < 0.0001), cluster formation (FCS; p < 0.01) 
and abnormal morphology (p < 0.001) compared to 
serum-free DMEM. Cluster formation and shape changes 
during FCS-DMEM culture were more pronounced than 
with SF-DMEM. SF-DMEM or FCS-DMEM stimulated 
these changes to chondrocytes at the injury with only 
small effects on distant cells. Hyperosmolarity inhibited 
the morphological and volume changes to chondrocytes 
induced by FCS-DMEM (p < 0.001) and the injured 
cartilage had the appearance of that in serum-free DMEM. 
Raised osmolarity may therefore have benefit in preserving 
the morphological phenotype of chondrocytes at the site of 
injury, and thus promote more effective integrative repair 
in partial-thickness cartilage injury.
Keywords: Cartilage, chondrocyte, injury, clustering, 
morphology, serum, synovial fluid, hyper-osmolarity, 
culture.
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Introduction
It is well established that the ability of adult articular 
cartilage to repair is critically dependent on whether or 
not an injury penetrates the full thickness to the calcified 
cartilage of subchondral bone (Hunziker, 2002). Injuries 
which breach the bone expose the vascular system and 
bone marrow to the defect void, and can stimulate an 
intrinsic cartilage ‘repair’ response (Steadman et al., 2001). 
This involves fibrin clot formation, vascular invasion and 
recruitment of mesenchymal stem cells into the defect, 
resulting in chondrogenesis at the wound site. However, 
the repair is fibro-cartilaginous (i.e. scar tissue) in nature, 
and there is a change in the morphology of chondrocytes 
from their classical ‘normal’ elliptical/rounded shape to 
an abnormal morphology more characteristic of a de-
differentiated ‘fibroblastic’ phenotype (Hunziker, 1999). 
The extracellular matrix (ECM) formed generally has a 
higher ratio of collagen type I to II, less proteoglycan 
(aggrecan) and inferior biomechanical properties and little 
morphological or structural similarity to hyaline cartilage, 
and is therefore vulnerable to degeneration (Knutsen et 
al., 2004).
 In contrast, partial-thickness injuries cannot be accessed 
by blood-borne cells and do not heal. Their appearance 
several months later is similar to that at the time of 
injury and they appear to be inert unlike similar defects 
in immature articular cartilage which show evidence of 
recovery (Wei et al., 1997; Namba et al., 1998). Recent 
work suggests that the response of cartilage to these injuries 
is not, in fact, negligible and that there are potentially 
important cellular changes occurring at the injury site. For 
example, following culture of human cartilage subjected to 
partial-depth injury, some changes to chondrocytes have 
been described (Lyman et al., 2012). In addition, Seol et 
al. (2012) have reported the presence of chondrogenic 
progenitor cells (CPCs), possibly attracted by ‘alarmins’ (or 
damage associated molecular pattern molecules) released 
by necrotic chondrocyte death. It has been suggested 
that CPCs actively migrate to the site of injury following 
short-term enzymatic treatment of cartilage (Seol et al., 
2014). Studies of the cellular response to these injuries 
are therefore of considerable interest as they might clarify 
why effective repair does not occur.
 Clearly, partial-thickness injuries will damage 
components of the ECM leading to complex changes 
including disruption of the collagen type II structure 
and progressive leaching/loss of matrix proteoglycans 
(Patwari et al., 2003). The damage to collagen architecture 
will reduce the restraining force on the partially-inflated 
aggrecan molecules (Maroudas, 1976), resulting in 
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further imbibition of water/tissue swelling at the injury 
(Maroudas and Venn, 1977). The osmolarity of cartilage 
interstitial fluid, and thus that to which the chondrocytes 
are normally exposed, is higher than that of normal tissue 
culture solutions (approx. 350-450 mOsm depending on 
cartilage zone, compared to approx. 280-340 mOsm; Urban 
et al., 1993). Thus, cartilage injury would be expected 
to cause interstitial osmolarity at/near the injury to fall 
towards that of the extracellular solution. Chondrocyte 
volume is directly influenced by osmolarity (Bush and Hall, 
2001a) and this has a powerful effect on cellular responses, 
including ECM metabolism (Urban et al., 1993). For 
example, alterations to the osmotic environment regulate 
the expression of the chondrogenic transcription factor 
SOX9 (de Crombrugghe et al., 2000) that is essential for 
the expression of many genes encoding ECM proteins, 
including collagen type II (Col2a1) and aggrecan (Tew 
et al., 2009). Matrix damage may also promote access 
of growth factors and other agents in the extracellular 
solution (i.e. serum or synovial fluid in culture medium) 
and these may stimulate chondrocyte ECM metabolism 
and/or mitogenic activity (Trippel, 1995; Fortier et al., 
2002; Cucchiarini et al., 2005; Byun et al., 2013).
 Protecting chondrocytes against the deleterious effects 
of swelling through reduced extracellular osmolarity and 
excessive growth factor stimulation might provide an 
optimal environment to direct chondrocytes to produce 
an appropriate ECM to repair the cartilage from partial-
thickness injury. While there have been extensive studies 
on the response of cartilage to these injuries (Hunziker, 
1999; Hunziker, 2002; Redman et al., 2004), there has 
been less attention paid to the effects of medium osmolarity 
and serum/growth factors (Hunziker, 2001) which may 
influence chondrocyte properties at the site of injury. 
Raising osmolarity reduces chondrocyte death following 
impact injury (Bush et al., 2005), scalpel cutting (Amin 
et al., 2008; Amin et al., 2009) and cartilage drilling 
(Farhan-Alanie and Hall, 2014). It has also been shown that 
repair of rat cartilage in vivo was more effective following 
partial-thickness injury performed in the presence of a 
hyper-osmotic (600 mOsm) irrigation solution compared 
to normal saline (approx. 280 mOsm) (Eltawil et al., 2015).
 As a first step towards clarifying the response of 
chondrocytes to cartilage injury, we have performed 
reproducible partial-thickness injury on bovine 
osteochondral explants. These have then been cultured 
in the presence or absence of synovial fluid (SF) or foetal 
calf serum (FCS) in tissue culture medium of normal 
(340 mOsm) or raised osmolarity (600 mOsm). Using 
confocal scanning laser microscopy (CLSM) and imaging 
methods, we have then quantified the response (viability, 
volume, morphology, clustering) of fluorescently-labelled 
in situ chondrocytes at and distant from the injury. Our 
results demonstrated that there are profound changes to 
chondrocyte properties at the site of injury which can be 
suppressed by removal of FCS or raised osmolarity.
Materials and Methods
Biochemicals and solutions
Biochemicals were from Invitrogen Ltd. (Paisley, UK) 
or Sigma-Aldrich (Poole, UK) unless stated otherwise. 
Standard culture medium was Dulbecco’s Modified 
Eagle’s Medium (serum-free DMEM; 340 mOsm, 37 °C, 
5 % CO2, pH 7.4) containing penicillin/streptomycin 
(100 U/mL and 100 µg/mL, respectively). The viability 
probe, 5-chloromethylfluorescein diacetate (CMFDA) 
and the nucleic acid dye propidium iodide (PI) were 
prepared as described (Amin et al., 2008). Formaldehyde 
solution (4 % v/v in saline, pH 7.3) was from Fisher 
Scientific (Loughborough, UK). For some experiments, 
serum-free DMEM was modified by addition of 10 % 
bovine synovial fluid (SF-DMEM; 340 mOsm) or 10 % 
foetal calf serum (FCS-DMEM; 340 mOsm). SF was 
taken aseptically from fresh (within 24 h of slaughter) 
healthy bovine metacarpophalangeal joints, centrifuged 
(Hettich Zentrifugen 32R, 21 °C, 1157×g, 10 min) and the 
supernatant stored (−20 °C) until required. When required, 
sucrose was added for hyperosmolarity experiments, with 
osteochondral explants exposed to either (a) normal saline 
(340 mOsm) or (b) hyperosmolar saline (600 mOsm; 
Amin et al., 2010) 5 min before and 5 min after the 
application of injury to allow chondrocytes to respond 
to altered osmotic environment and then cultured under 
four conditions: (a) serum-free DMEM (340 mOsm), (b) 
FCS-DMEM (340 mOsm), (c) hyperosmolar serum-free 
DMEM (600 mOsm) or (d) hyperosmolar FCS-DMEM 
(600 mOsm).
Cartilage preparation, application of scalpel injury 
and fluorescent labelling
Metacarpophalangeal joints of 3 year-old cows were 
prepared (Amin et al., 2008) and full-depth osteochondral 
explants trimmed to approx. 5 × 3 × 1 mm. The articular 
surface was then injured by a single pass of a fresh No. 11 
blade in a ‘push-through mode’ down the long axis of the 
explant (Amin et al., 2009). The injury was always produced 
in the same direction, avoiding additional movements of 
the scalpel, cutting carefully without penetrating the bone. 
The typical depth of the injury was approx. 50 µm, whereas 
the thickness of the explant was approx. 800 µm. The 
explants were cultured in experimental media for up to 
14 d, with media changed on alternate days. At appropriate 
time points and during the last hour of culture, explants 
were incubated with CMFDA and PI (12.5 and 5 µM, 
respectively) to label living or dead cells, respectively. 
Explants were then washed in phosphate-buffered saline 
(PBS), fixed in 4 % formaldehyde (30 min) and mounted 
for imaging (Amin et al., 2008).
Confocal laser scanning microscopy (CLSM)
A Zeiss Axioskop LSM510 upright CLSM (Zeiss (UK), 
Welwyn Garden City, UK) was used with Ex of 488 nm and 
543 nm for the fluorophores CMFDA and PI, respectively. 
Emission light was passed through a band-pass filter 
(505-530 nm) and long-pass filters (650 nm), respectively. 
Fluorescently-labelled in situ chondrocytes were imaged 
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in the axial plane at, and ~400 µm distant, from the injury. 
Chondrocyte viability was assessed using a low power 
objective (× 10 dry, NA = 0.3) (Amin et al., 2009), and 
injury width and chondrocyte morphology studied using 
a high power (× 40, NA = 0.8) dipping water (DW) lens. 
The same region of interest (ROI) was applied for all 
measurements of chondrocyte viability/morphology. The z 
stack images comprising single confocal sections typically 
to a depth of 50 µm for high and 100 µm for low power 
objective magnification measurements were collected at 
intervals of 1 µm and 10 µm, respectively, and frame size 
of 1024 × 1024 pixels. Optical sections were converted into 
three-dimensional (3D) reconstructions using Volocity™ 
(Improvision, Coventry, UK) software (Amin et al., 2008).
Quantification of live and dead chondrocytes
Low-power axial confocal images were analysed for live/
dead cell counting using the green/red staining pattern, 
respectively, with an automated counting protocol on 
Volocity™ (Amin et al., 2009). A 3D ROI was created to 
encompass the injured site with dimensions of x, y, z of 400, 
913 and 100 µm, respectively. Cell death distant from the 
injury was determined by applying ROIs with dimensions 
of x, y, z of 200, 913 and 100 µm, respectively, on both 
sides of the injury and the average calculated. Therefore, 
the area was ~200 µm distant from the injury on either 
side on the same image. The counting protocol identified 
objects (individual cells) as green (live) or red (dead) 
on the basis of percentage threshold intensity in the two 
channels. The mean number of live/dead cells in each ROI 
was calculated and % PI-labelled cells (i.e. percentage cell 
death, PCD) determined as 100 × (number of dead cells/
number of dead and live cells) %. The high power (× 40 
DW) axial confocal images were analysed by Volocity™ 
software to determine the width of the injury by drawing 
two straight lines on either side of the injury enclosing 
the area containing no cells and measuring the distance 
between the lines. Chondrocyte volume/morphology 
were determined by analysing high power images ‘at’ and 
‘distant from’ the injury within the specified ROI with the 
dimensions of x, y, z of 228, 228 and 50 µm, respectively, 
applied at the injured site and approximately 400 µm distant 
from the injury on separate images.
Volume and morphological analysis of in situ 
chondrocytes
Quantitative data regarding volume and 3D morphological 
analysis of in situ chondrocytes were obtained from the 
CLSM (× 40 DW objective) images using a measurement 
protocol on Volocity™. In order to determine chondrocyte 
volume, it was necessary to identify the cell edge and this 
was done using a threshold segmentation method, and 
volume determined individually. Volume was calibrated by 
determining the baseline threshold intensity of fluorescent 
latex beads (Fluoresbrite™, Polyscience Inc., Warrington, 
UK; Bush and Hall, 2001a).
 Chondrocytes in superficial zones of bovine cartilage 
typically exist in pairs (Sasazaki et al., 2008) and thus we 
defined a cluster as consisting of ≥ 3 chondrocytes within the 
lacunar space. Chondrocytes lying at the edges of images 
were not included in the analysis. The number of cells in 
a cluster was counted manually because it was impossible 
to segment individual cells as the cell membranes were 
frequently touching. The total number of chondrocytes in 
CLSM projections in a fixed ROI was counted, and the 
percentage of cells involved in forming clusters calculated 
as: % cells in a cluster = 100 × (number of cells forming 
clusters/total number of cells) %. For measurements of 
cell morphology, the cell body of individual chondrocytes 
was measured along the longest (y) axis of the cell in 3D 
using Volocity™. Chondrocytes which were elliptical/
spheroidal with no cytoplasmic processes were considered 
morphologically ‘normal’. However, cells with elongated/
non-spheroidal shapes, frequently including cytoplasmic 
processes, were considered morphologically ‘abnormal’ 
(Bush and Hall, 2003). These chondrocytes had a variety 
of characteristics based on (a) shape of cells, (b) presence 
or absence of cytoplasmic processes, and (c) presence 
of single or multiple processes (examples illustrated in 
Results). The percentage of abnormal chondrocytes was 
calculated as: % abnormal chondrocytes = 100 × (number 
of abnormal cells/total number of normal and abnormal 
cells) %.
Data presentation and analysis of results
Data were presented as mean ± standard error of the 
mean (SEM) with N representing the number of different 
animals, n the number of explants and nʹ the number of 
cells for each experimental condition. Statistical tests and 
graphs were generated using Graph Pad Prism 6 (GraphPad 
Inc., La Jolla, CA, USA). Unpaired, two-tailed, Student’s 
t-tests were used to compare means within groups. One-
way analysis of variance (one-way ANOVA) was used to 
compare data between groups. A significant difference was 
accepted when p < 0.05. ‘a’ was used to show significant 
difference using Student’s t-tests within groups, ‘b’ was 
used to show significant difference using ANOVA between 
the groups compared, and ‘c’ was used to indicate a 
statistically significant difference using the Student’s t-test 
between data obtained at and distant from the injury and 
between standard and hyperosmolar culture conditions. 
Single, double and triple symbols showed the level of 
significance for p < 0.05, 0.01 and 0.001, respectively.
Results
Response of cartilage and chondrocytes following 
culture with serum-free DMEM, synovial fluid-
DMEM (SF-DMEM) or foetal calf serum-DMEM 
(FCS-DMEM)
Fig. 1A(a-j) shows the overall response of cartilage and 
in situ chondrocytes at the site of scalpel injury following 
culture under different conditions. After 14 d in serum-free 
DMEM, the rounded morphology of chondrocytes did not 
change (Fig. 1A(a-d)). However, by day 14 in the presence 
of synovial fluid (SF-DMEM; Fig. 1A(e-g)) or foetal calf 
serum (FCS-DMEM; Fig. 1A(h-j)), abnormal chondrocyte 
morphology was evident with cells developing long 
cytoplasmic processes in the direction of the scalpel injury.
 In serum-free DMEM, injury width increased 
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ANOVA; Fig. 1B). For explants in SF-DMEM and FCS-
DMEM, a significant increase was also observed but only 
up to day 7, since between days 7 and 14, the width of the 
injury decreased significantly for both conditions (p < 0.01 
and p < 0.001, respectively, by Student’s t-tests). The 
width was also less compared to that of explants cultured 
in serum-free DMEM (Fig. 1B; p < 0.001 and p < 0.01, 
respectively). The images (Fig. 1A(g,j)) indicated that 
this was most likely due to the presence of abnormal 
chondrocytes in the injury cleft resulting from the presence 
of SF or FCS in the culture media.
 Images of fluorescently-labelled cells at the injury 
demonstrated a significant decrease in PI-labelled material 
in the presence of SF-DMEM and FCS-DMEM even at day 
3 (Fig. 1A(e-g), (h-j) and Fig. 1C). However, there was 
no such effect in serum-free DMEM with red fluorescent 
PI-labelling clearly persisting (Fig. 1A(a-d) and Fig. 1C) 
with no significant change (p > 0.05 by ANOVA) over 
14 d of culture. In marked contrast, the % PI-labelled 
cells at the injury in the presence of SF-DMEM and 
FCS-DMEM was significantly less throughout the culture 
period compared to serum-free DMEM (Fig. 1C; p < 0.01 
by ANOVA). Thus, in the presence of SF-DMEM and 
FCS-DMEM, PI-labelling decreased by approx. 80-90 % 
compared to serum-free DMEM throughout the culture 
period. In addition, at day 3 there was significantly more 
PI-labelling in explants cultured in SF-DMEM compared 
to FCS-DMEM (Fig. 1C; p < 0.01 by Student’s t-test), 
suggesting that at this point FCS was more effective at 
removing PI-labelled material.
Morphological characteristics of chondrocytes at, or 
distant from, the injury following culture with SF-
DMEM or FCS-DMEM
Chondrocyte morphology at the injury was relatively 
‘normal’ (elliptical/spheroidal in shape with no cytoplasmic 
processes) at days 0, 3 and 7 under all culture conditions 
(Fig. 1A). However, by day 14, chondrocytes displayed 
marked shape changes in the presence of SF-DMEM and 
FCS-DMEM, which were characterised by production of 
cytoplasmic processes, cell enlargement and elongation of 
the cell body (examples in Fig. 2A(a-f)). In contrast, cells 
in the injured region of cartilage cultured in serum-free 
DMEM still exhibited normal morphology. In order to 
compare these changes with cells distant from the injury, 
properties of chondrocytes (abnormal morphology, cell 
volume, length of cell body) were quantified as described 
(see Materials and Methods) with pooled data presented 
in Fig. 2B-D. The morphological characteristics of 
chondrocytes at day 14 were compared between relatively 
‘normal’ and ‘abnormal’ chondrocytes following culture in 
serum-free DMEM and SF- or FCS-DMEM respectively.
 After 14 d of culture, 15 ± 3 % cells in SF-DMEM 
and 31 ± 5 % cells in FCS-DMEM showed significant 
morphological changes compared to chondrocytes at 
the injury in serum-free DMEM (Fig. 2B(a); p = 0.0013 
and p < 0.0001, respectively) and chondrocytes at day 
0 (p < 0.01 and p < 0.001, respectively) which were all 
morphologically ‘normal’. Distant from the injury after 
14 d, chondrocytes with abnormal morphology were only 
very occasionally observed (Fig. 2B(b)). However, there 
were more chondrocytes with processes during culture 
with FCS-DMEM compared to SF-DMEM (Fig. 2B(a); 
p < 0.01), suggesting a more potent effect of FCS. The 
percentage of abnormal cells was significantly greater as 
compared to distant from the injury in explants cultured 
with SF-DMEM or FCS-DMEM (Fig. 2B(b); p < 0.05). 
Additionally, in the presence of serum-free DMEM, 
chondrocyte morphology remained unaffected at, or distant 
from, the injury (Fig. 2B(a,b)).
 There was an overall three-fold increase in the volume 
of morphologically-abnormal chondrocytes at the injury 
in the presence of SF-DMEM or FCS-DMEM compared 
to serum-free DMEM (Fig. 2C(a)). The average volume 
of individual abnormal chondrocytes by day 14 was 
significantly higher in SF-DMEM and FCS-DMEM 
compared to serum-free DMEM and also in comparison 
to the volume of chondrocytes at day 0 (Fig. 2C(a); 
p < 0.0001). However, distant from the injury in the 
presence of SF-DMEM or FCS-DMEM, the volume 
of chondrocytes was significantly lower than those at 
the injury (Fig. 2C(b); p < 0.0001). In the presence of 
serum-free DMEM, the volume of chondrocytes remained 
unaffected at or distant from the injury.
 The length of the cell body of individual abnormal 
cells at the injury increased by approximately 4-fold in 
the presence of SF-DMEM and FCS-DMEM compared 
to serum-free DMEM and also day 0 (Fig. 2D(a); 
p < 0.0001). The length of cell bodies at the injury was 
significantly greater compared to those distant from the 
injury following culture in SF-DMEM or FCS-DMEM 
(Fig. 2D(b); p < 0.0001). In serum-free DMEM, the length 
of cell bodies remained unaffected at or distant from the 
injury, suggesting no morphological abnormalities. These 
results suggested that by day 14, chondrocyte volume/
morphology remained unaffected in serum-free DMEM but 
displayed marked changes in the presence of SF-DMEM 
or FCS-DMEM.
 Measurements of individual chondrocyte volumes 
were performed at an earlier time point, i.e. day 3, because 
later during the culture chondrocytes formed clusters and 
it was difficult to accurately segment the cells. After 7 d 
in culture, measurements for clusters were performed 
since with further culture, due to the complex nature of 
the changes occurring, identification of individual cells in 
a cluster was unclear. The morphology of chondrocytes 
was unaltered during the first week in all the culture 
conditions, and therefore pooled data for days 3 and 7 
from all morphologically ‘normal’ chondrocytes following 
culture under various conditions are shown in Fig. 3.
 At day 3, chondrocyte volume increased significantly 
under the influence of different culture media. At day 0, 
chondrocyte volume at the injury was 711 ± 25 µm3 and it 
remained constant by day 3 when explants were cultured 
in serum-free DMEM (Fig. 3A(a)). Chondrocyte volume at 
the injury in SF-DMEM or FCS-DMEM culture increased 
~ 55 % at day 3 compared to serum-free DMEM and 
~ 70 % compared to day 0 (Fig. 3A(a); p < 0.0001 for 
both time points) and was greater with SF-DMEM and 
FCS-DMEM compared to that distant from the injury (Fig. 
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Fig. 4. Heterogeneity of chondrocyte morphology by day 14 at the injury in response to different culture media. Axial 
CLSM reconstructions (× 40 DW) of fluorescently-labelled chondrocytes at day 14, (A(a, b, c)) superficial 30 µm and 
(A(d, e, f)) a further deep 20 µm of the full depth cartilage explants cultured in serum-free DMEM, SF-DMEM and 
FCS-DMEM, respectively, and (B(a, b)) surface 30 µm and (B(c, d)) a further deep 20 µm of the cartilage explants 
without superficial layers cultured in serum-free DMEM or FCS-DMEM, respectively. Scale bar for all panels = 25 µm.
213 www.ecmjournal.org
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3A(b); p < 0.0001 and p = 0.0002 for both conditions). 
However, in serum-free DMEM, no difference in volume 
was observed at or distant from the injury (Fig. 3A(b)).
 Chondrocyte clustering was a feature routinely 
observed at the injury with SF-DMEM or FCS-DMEM 
culture, but only rarely with serum-free DMEM. At day 
0 in normal osteochondral explants, chondrocytes were 
typically present in pairs (Sasazaki et al., 2008) and only 
approximately 3 % of chondrocytes within the region of 
interest (ROI) formed approximately 3-4 clusters with 
no more than 3 cells per cluster. However, the number 
of clusters formed in the presence of FCS-DMEM was 
significantly higher compared to day 0 (p < 0.05) and 
serum-free DMEM at day 7 (p < 0.01) (Fig. 3B(a)), and 
also those present in SF-DMEM culture (p < 0.05; Fig. 
3B(a)). This suggested a more potent action of FCS on 
cluster formation at the site of injury compared to SF. 
Distant from the injury, the number of clusters formed was 
very low under all conditions (Fig. 3B(b)) and significantly 
less for FCS-DMEM compared to those present at the 
injury (p = 0.03).
 In explants cultured with FCS-DMEM, a significantly 
higher percentage of chondrocytes formed clusters 
(27 ± 4 %) compared to those in serum-free DMEM 
(7 ± 3 %; p < 0.05) and the percentage of chondrocytes 
forming clusters at day 0 (Fig. 3C(a); 3 ± 1 %, p < 0.05). 
However, in the presence of SF-DMEM, 11 ± 4 % 
chondrocytes formed clusters but the effect was rather 
weak, and compared to serum-free DMEM, was not 
statistically significant. Despite this, in explants cultured 
with FCS-DMEM, a significantly higher percentage of 
chondrocytes formed clusters at, compared to distant, from 
the injury (Fig. 3C(b); p = 0.01) again suggesting a more 
potent action of FCS-DMEM compared to SF-DMEM. 
Clusters of chondrocytes were only rarely observed distant 
from the injury (Fig. 3C(b)). These results suggested that 
chondrocyte clustering was triggered at the injury in the 
presence of SF-DMEM and FCS-DMEM compared to 
serum-free DMEM, and FCS appeared to be more potent 
compared to SF.
Chondrocyte morphology in response to various 
culture media in superficial and deeper layers 
following cartilage injury
In injured osteochondral explants, the morphology of 
chondrocytes cultured in serum-free DMEM was normal 
after 14 d, both in the superficial and deeper regions of 
cartilage (Fig. 4A(a,d)). In the presence of SF-DMEM 
or FCS-DMEM, chondrocytes showed marked abnormal 
morphology, which was restricted to the superficial zones 
(approx. 30 µm depth) of cartilage (Fig. 4A(b,c)). However, 
the chondrocytes residing deeper than this demonstrated 
relatively normal volume/morphology (Fig. 4A(e,f)). 
Similarly, when cartilage explants without subchondral 
bone were injured, only chondrocytes in the superficial 
layers at the injury demonstrated abnormal morphology in 
the presence of SF-DMEM or FCS-DMEM, whereas the 
morphology of chondrocytes at the injury following culture 
in serum-free DMEM was unaltered (data not shown). 
This suggested that the heterogeneous population of cells 
evident at the injury were morphologically-abnormal 
chondrocytes induced by SF or FCS, and that cells or other 
factors from bone were not involved.
 In further experiments, the superficial zone from 
osteochondral explants was surgically removed, and then 
the injury performed and the samples cultured (Fig. 4B). 
The chondrocytes still displayed marked morphological 
changes in the presence of FCS-DMEM compared to 
serum-free DMEM where the morphology remained 
relatively normal (Fig. 4B(a,c) versus (b,d)). Thus, FCS-
DMEM altered the morphology of chondrocytes within the 
deeper cartilage regions in a similar way to those in the 
superficial zones. This suggested that FCS-DMEM could 
induce abnormal morphology to chondrocytes deeper into 
cartilage, and that these morphological changes were not 
an exclusive property of chondrocytes in the superficial 
regions of cartilage.
Injury width and chondrocyte properties following 
culture in normal or hyperosmotic media with or 
without FCS
The effects of FCS on chondrocyte morphology at the injury 
(volume, clusters, abnormal morphology) were largely 
overcome by raising the osmolarity of the culture medium. 
The measurements of morphological characteristics of 
chondrocytes (volume, abnormal chondrocytes and length 
of cell bodies) were performed at day 14. At the start 
of the experiment (day 0), the width of the injury was 
significantly less in hyperosmolar serum-free DMEM 
compared to serum-free DMEM (Fig. 5A(a,b) and Fig. 
5B; p < 0.001). By day 14, injury width had increased 
significantly in serum-free DMEM, but was unchanged in 
hyperosmolar serum-free DMEM, whereas the width was 
significantly less in the presence of FCS-DMEM because 
of the presence of abnormally-shaped chondrocytes (Fig. 
5A(m) and Fig. 5B; p < 0.001). Abnormal chondrocyte 
morphology was evident in FCS-DMEM (Fig. 5A(m)) but 
not in hyperosmolar FCS-DMEM (Fig. 5A(n)), serum-free 
DMEM or hyperosmolar serum-free DMEM (Fig. 5A(k,l)), 
as under these three conditions chondrocyte morphology 
remained relatively normal (i.e. spheroidal).
 Chondrocyte volume following culture in serum-free 
DMEM, was unchanged after 14 d, but was significantly 
increased in FCS-DMEM (Fig. 6A(a); p < 0.0001). In 
hyperosmolar serum-free DMEM, chondrocytes were 
initially shrunken by approximately 24 % (Fig. 6A(b); 
p < 0.001) but their volume recovered by day 14 to a level 
not significantly different from that present in serum-free 
DMEM. At day 14, cell volume was significantly greater in 
FCS-DMEM compared to the serum-free DMEM control, 
but was markedly reduced (p < 0.001) in hyperosmolar 
FCS-DMEM (Fig. 6A(b)). Chondrocytes with cytoplasmic 
processes were rarely observed following culture in 
serum-free DMEM (Fig. 6B(a)). However, their presence 
was markedly stimulated by culture with FCS-DMEM 
(p < 0.001) and completely abolished in hyperosmolar 
FCS-DMEM (Fig. 5A(n) and Fig. 6B(b)). The normal 
length of the chondrocyte body in serum-free DMEM was 
approximately 15 µm, and this increased by approximately 
4-fold in the presence of FCS-DMEM to approximately 
56 µm (Fig. 6C(a); p < 0.001). In hyperosmolar FCS-
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markedly reduced (p < 0.001) to levels close to those 
observed in hyperosmolar serum-free DMEM (17 ± 0.4 µm 
and 16 ± 0.4 µm, respectively; Fig. 6C(b)).
 For measurements of chondrocyte clusters, a shorter 
incubation period of 7 d was required because after 
this chondrocytes were too tightly packed making 
discrimination of the membrane and thus identification 
of the cells inaccurate. In the presence of FCS-DMEM, 
the number of clusters and percentage of chondrocytes 
forming clusters at the injury increased significantly 
compared to serum-free DMEM (p = 0.02 and p = 0.01, 
respectively) and also in comparison to day 0 (Fig. 7A(a) 
and 7B(a); p < 0.01 and p < 0.001). By day 7, the average 
number of clusters and percentage of chondrocytes forming 
clusters remained significantly less in the presence of 
hyperosmolar serum-free DMEM and hyperosmolar 
FCS-DMEM compared to serum-free DMEM and normal 
osmolarity FCS-DMEM, respectively (p < 0.05 for both 
the conditions; Fig. 7A(b) and 7B(b)). Taking these results 
together, FCS-DMEM increased chondrocyte volume, 
the % of cells with processes, the length of the cell body, 
the number of clusters and the % of chondrocytes within 
clusters. However, all these parameters were markedly 
suppressed (0.01 < p < 0.001) if the osmolarity of the 
FCS-DMEM was raised to 600 mOsm.
Discussion
Partial-thickness cartilage injury initiated substantial 
changes to in situ chondrocytes, particularly following 
culture with synovial fluid (SF-DMEM) or foetal calf serum 
(FCS-DMEM). At the site of scalpel injury during culture 
in serum-free DMEM, despite an increase in injury width, 
there were no other significant changes to chondrocyte 
properties. In marked contrast, when injured explants 
were cultured with SF-DMEM or FCS-DMEM there were 
increases in cell volume, development of morphologically-
abnormal cells with extended cytoplasmic processes, 
and cell clustering. Since relatively minor changes to 
chondrocytes distant from the injury were observed in 
SF-DMEM or FCS-DMEM culture, this suggested that 
penetration of factors at the site of injury could account for 
the development of these abnormal chondrocyte properties. 
However, the morphological changes to chondrocytes 
observed at the injury during culture with FCS-DMEM, 
were largely abolished when medium osmolarity was 
increased (hyperosmolar FCS-DMEM). These results 
raise a number of key questions about the response of 
chondrocytes following partial-thickness injury.
 Culture medium composition strongly influenced 
the properties of injured cartilage and chondrocytes. In 
serum-free DMEM, injury width increased over 14 d 
(Fig. 1B), probably due to collagen damage, leading to 
further water imbibition by matrix proteoglycans (PGs) 
(Maroudas, 1976) resulting in tissue swelling at the 
site of injury. This coupled with the progressive loss of 
glycosaminoglycans (GAGs) during culture (Torzilli and 
Grigiene, 1998), would decrease extracellular osmolarity 
and stimulate chondrocyte swelling (Bush and Hall, 
2001a). However, chondrocyte volume at the site of injury 
did not change during culture (Fig. 2C(a)) suggesting that 
volume regulation had occurred (Bush and Hall, 2001b). 
For explants cultured in SF-DMEM or FCS-DMEM, injury 
width also increased, but between 7 and 14 d it decreased 
(Fig. 1B) because of the presence of chondrocytes with 
abnormal morphology (Fig. 1A(g,j)). This was probably 
due to the enhanced permeability of the damaged cartilage 
(Armstrong and Mow, 1982; Byun et al., 2013) allowing 
factors present in SF or FCS access to the chondrocytes at 
and near the injury. In contrast, chondrocyte morphology 
distant from the injury was relatively normal (Fig. 2B(b) 
and Fig. 2D(b)), supporting the notion that the undamaged 
matrix retained its relative impermeability to morphogenic 
factors. As a first step towards identifying these factors, 
preliminary experiments were performed with heat-
inactivated FCS (HI-FCS; 56 °C, 30 min). The results 
indicated no difference in the changes occurring at the 
injury site with chondrocytes with abnormal morphology 
being observed following culture in both conditions after 
14 d (Karim, A. unpublished results). This temperature 
treatment destroys the complement system (Triglia and 
Linscott, 1980) indicating that these elements are probably 
not involved in mediating the morphological changes. 
Future experiments using other procedures to eliminate 
other possible ingredients in serum, would be of particular 
interest in order to identify the active agent(s) responsible 
for inducing the morphological changes.
 There was a significant loss of dead (PI-labelled) 
chondrocytes following culture in the presence of SF-
DMEM and FCS-DMEM compared to serum-free DMEM 
(Fig. 1A,C). This was probably due to the presence of 
nucleic acid-degrading enzymes (Zhou et al., 2011). As 
the fluorescent dye (PI) was added 1 h prior to imaging, 
this suggests little additional cell death after injury. This 
was probably because of the focal nature of the injury, 
as relatively non-specific damage (e.g. impact injury) 
may result in progressive cell death (Redman et al., 
2004). Notably, at day 3, the effect of FCS on PI-labelled 
chondrocytes was greater than SF (Fig. 1C), providing 
additional cautionary evidence (e.g. Martin et al., 2002) 
that FCS-supplemented culture media may have a more 
potent effect on chondrocyte and cartilage properties 
compared to SF.
 By day 14, chondrocyte properties at the site of 
injury were markedly altered following culture with SF-
DMEM or FCS-DMEM (Fig. 2A-D). The orientation of 
the cytoplasmic processes in FCS-DMEM was similar to 
that previously reported (Lyman et al., 2012); however, 
their presence in SF-DMEM and absence in serum-free 
DMEM (Fig. 1A) have not yet been described. Distant 
from the injury, these effects were markedly reduced but 
still present, and significantly greater than those observed 
during culture with serum-free DMEM. The volume of 
chondrocytes with normal morphology near the injury 
increased in the presence of SF or FCS compared to 
serum-free DMEM (Fig. 3A(a)). The initial volume of 
chondrocytes (711 ± 25 µm3) was within the range of 
superficial zone cells in intact (uninjured) bovine articular 
cartilage (Bush and Hall, 2001a). By day 3, there was a 
55 % increase in the chondrocyte volume near the injury 
in SF-DMEM or FCS-DMEM compared to serum-free 
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injury exhibited almost no cluster formation (Fig. 3B(b) 
and C(b)), probably because the matrix was relatively 
intact thereby hindering penetration of cluster-stimulating 
factors.
 Chondrocytes with abnormal morphology were 
observed in superficial regions of injured explants cultured 
in SF-DMEM or FCS-DMEM but not in serum-free 
DMEM (Fig. 1A(d,g,j) and 2B). The imaging method 
visualised cells to a depth of approximately 30 µm; 
however, imaging a further 20 µm deeper into this 
region demonstrated that chondrocyte morphology was 
spheroidal and relatively ‘normal’ (Fig. 4A(e,f)). This 
raised the question of whether only chondrocytes within 
the superficial regions were sensitive to the effects of SF or 
FCS. However, when the superficial layer of cartilage was 
removed, following injury the cells in deeper layers also 
changed shape (Fig. 4B(b,d)) in the presence of FCS, and 
thus the ability to alter morphology did not appear to be a 
unique feature of chondrocytes in the superficial regions 
of injured cartilage.
 In hyperosmotic serum-free DMEM at day 0, injury 
width was less compared to serum-free DMEM resulting 
in reduced chondrocyte death (Fig. 5B). This might appear 
to conflict with a recently-published in vivo study where 
injury width was not significantly different between media 
of normal or raised osmotic pressure (Eltawil et al., 2015). 
However, the cartilage injury was previously performed on 
the whole joint whereas in the current work osteochondral 
explants were used. Thus, in the latter model, cartilage 
shrinking may have occurred leading to reduced injury 
width. Interestingly, the injury width following culture in 
hyperosmolar serum-free DMEM did not change over 14 d 
whereas it increased by more than 2-fold in serum-free 
DMEM (Fig. 5B). A ‘protective’ effect of raised osmolarity 
has already been described following injury to cartilage 
subjected to impact (Bush et al., 2005), and scalpel injury 
both in vitro (Amin et al., 2008) and in vivo (Eltawil et al., 
2015).
 Injury width decreased in FCS-DMEM by day 14 
due to the development of abnormal chondrocytes (Fig. 
5A(m)); however, no abnormal cells were observed 
in hyperosmolar FCS-DMEM (Fig. 5A(n)). Several 
properties of chondrocytes previously shown to be altered 
in SF-DMEM or FCS-DMEM (Fig. 2) were significantly 
suppressed in hyperosmolar serum-free DMEM or 
hyperosmolar FCS-DMEM (Fig. 6). Chondrocyte volume 
was reduced (Fig. 6A(b)), and there were almost no cells 
with cytoplasmic processes or with an increased cell body 
length compared to serum-free DMEM or FCS-DMEM 
(Fig. 6B and C). Thus, hyperosmolarity almost completely 
inhibited the chondrocyte volume and morphological 
changes observed with FCS-DMEM and the injured 
cartilage had the appearance of that in serum-free DMEM 
(Fig. 1A(d) compared to Fig. 5A(n)). [Note however that 
at day 14, PI-labelled chondrocytes were still observed 
in serum-free DMEM, whereas they had disappeared 
in hyperosmolar FCS-DMEM]. These results suggest a 
close association between the changes to chondrocyte 
morphology induced by FCS and their inhibition by 
increased culture medium osmolarity.
 Chondrocyte phenotype and expression of many genes 
encoding for cartilage extracellular matrix proteins are 
known to be strongly regulated by the SOX9 transcription 
factor (de Crombrugghe et al., 2000; Tew et al., 2005). 
This in turn is controlled by medium osmolarity (Tew et 
al., 2009) which is known to regulate the p38 mitogen-
activated protein kinase (MAPK) pathway in many 
organisms (Sheikh-Hamad and Gustin, 2004). One possible 
explanation for these results is that the raised osmolarity 
increases chondrocyte SOX9 mRNA stability and SOX9 
protein production (Tew et al., 2009) and overcomes the 
actions of SF-DMEM or FCS-DMEM which stimulate 
abnormal chondrocyte morphology, resulting in normal 
(spheroidal) cell shape. The results also demonstrated 
that increasing osmolarity reduced chondrocyte cluster 
formation and the % of chondrocytes in clusters, despite 
the presence of FCS (Fig. 7A and B). Thus, although there 
would appear to be deleterious effects on chondrocytes, 
these may be largely overcome by raising osmolarity. It 
is established that the mechanical properties of ‘repair’ 
tissue following injury are poor and may possess fibro-
cartilaginous characteristics (Hunziker, 1999; Hunziker, 
2002). The present results show that factors in SF or FCS 
may stimulate morphological and potentially phenotypic 
changes to chondrocytes which might not then produce 
mechanically-resilient cartilaginous-like tissue. However, 
raising osmolarity would appear to protect chondrocytes 
from these deleterious effects and perhaps in combination 
with growth factors (Hunziker, 2001) could stimulate 
more effective cartilage repair. Recent studies using a 
partial-thickness in vivo model showed that the repair 
score, type II collagen, aggrecan levels and injury width 
were significantly improved when injury was applied in the 
presence of elevated (600 mOsm) compared to ‘normal’ 
osmolarity (Eltawil et al., 2015).
 A key question was whether the abnormal cells 
observed at the injury were existing chondrocytes 
undergoing changes to morphology, or whether they 
were chondroprogenitor cells (CPCs) present within the 
superficial zone (Alsalameh et al., 2004; Dowthwaite 
et al., 2004) which had migrated to the injury. Recent 
work has suggested that CPCs may be attracted by 
chemotactic factors (collectively known as ‘alarmins’) 
from dead (necrotic) chondrocytes or in enzymatically-
treated cartilage, and stimulated to repopulate the injured 
site (Seol et al., 2012; Seol et al., 2014). While we do 
not believe our data allow a firm conclusion, there are 
some observations that are relevant. No morphologically-
abnormal cells were observed within injured cartilage 
cultured in serum-free DMEM (Fig. 1A(d)) despite the 
presence of dead (PI-labelled) chondrocytes. However, 
this could be because levels of ‘alarmins’ might be too 
low and the scalpel injury highly focused compared to 
wounding by blunt impact or scratching (Seol et al., 2012). 
In contrast, many abnormal cells were observed at the 
injury in SF-DMEM or FCS-DMEM despite the fact that 
dead cell material was removed relatively rapidly (e.g. 
day 3; Fig. 1A(e,h)). While chondrocytes with abnormal 
morphology were rarely observed distant from the injury 
(Fig. 2B(b)), there was no suggestion that they were 
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migrating in a preferential direction towards the injury 
(Karim, A. unpublished results). In addition, changes to 
chondrocyte shape were observed when the superficial 
layer was substantially removed suggesting that these 
changes were not exclusive to cells in this region (Fig. 
4B). In hyperosmolar FCS-DMEM, cells with processes 
were rarely observed (Fig. 6B(b)), which could be taken 
to indicate suppression of CPCs; however, it has been 
reported that raising medium osmolarity significantly 
increased chondrogenic gene expression during the course 
of chondrogenic differentiation of progenitor cells (Caron 
et al., 2013). There is no doubt, however, that both SF and 
FCS are key determinants of the altered cell morphology, 
and may stimulate existing chondrocytes at the site of 
injury, or act as a co-factor in the recruitment/migration 
of CPCs to the repair site.
 We have utilised CLSM and quantitative imaging to 
determine properties of in situ chondrocytes at and distant 
from a partial-thickness scalpel injury applied to a bovine 
osteochondral explant model. Culture in SF-DMEM or 
FCS-DMEM produced marked changes to properties 
of chondrocytes at the injury, stimulating increased cell 
volume, development of abnormal morphology and 
clustering, with minor effects on cells distant from the 
injury. The finding that increased osmolarity markedly 
suppressed the FCS-induced changes to chondrocytes 
suggested a common site of action and served to preserve 
normal chondrocyte morphology.
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